{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:47:10Z","timestamp":1744174030730},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.cct.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T14:08:40Z","timestamp":1207836520000},"page":"671-678","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of operational chronic infection endpoints for HCV vaccine trials"],"prefix":"10.1016","volume":"29","author":[{"given":"Minhee","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cct.2008.03.006_bib1","first-page":"35","article-title":"Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium","volume":"6","author":"Global surveillance and control of hepatitis C","year":"1999","journal-title":"J Viral Hepatitis"},{"issue":"8","key":"10.1016\/j.cct.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cct.2008.03.006_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2006.06.007","article-title":"Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States","volume":"131","author":"Nainan","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cct.2008.03.006_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.21162","article-title":"Hepatitis C databases, principles and utility to researchers","volume":"43","author":"Kuiken","year":"2006","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.cct.2008.03.006_bib5","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/jama.289.18.2413","article-title":"Chronic hepatitis C virus infection","volume":"289","author":"Flamm","year":"2003","journal-title":"Jama"},{"issue":"Suppl 1","key":"10.1016\/j.cct.2008.03.006_bib6","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/00042560-199802001-00003","article-title":"The importance of preventing hepatitis C virus infection among injection drug users in the United States","volume":"18","author":"Alter","year":"1998","journal-title":"J Acquir Immune Defic Syndr Human Retrovirol"},{"issue":"7","key":"10.1016\/j.cct.2008.03.006_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cct.2008.03.006_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1017\/S0950268806006388","article-title":"Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users","volume":"135","author":"Amin","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.cct.2008.03.006_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00535-007-2064-6","article-title":"The epidemiology of hepatitis C infection in the United States","volume":"42","author":"Rustgi","year":"2007","journal-title":"J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cct.2008.03.006_bib10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J Acquir Immune Defic Syndr Human Retrovirol"},{"issue":"3","key":"10.1016\/j.cct.2008.03.006_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jhep.2002.35065","article-title":"Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users","volume":"36","author":"Miller","year":"2002","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cct.2008.03.006_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrd2134","article-title":"Hepatitis C virus therapies","volume":"5","author":"Smith","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.cct.2008.03.006_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7150\/ijms.3.35","article-title":"Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease","volume":"3","author":"Chevaliez","year":"2006","journal-title":"Int J Med Sci"},{"issue":"20","key":"10.1016\/j.cct.2008.03.006_bib14","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.vaccine.2006.03.009","article-title":"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects","volume":"24","author":"Firbas","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cct.2008.03.006_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00535-007-2057-5","article-title":"Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments","volume":"42","author":"Wintermeyer","year":"2007","journal-title":"J Gastroenterol"},{"issue":"7053","key":"10.1016\/j.cct.2008.03.006_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cct.2008.03.006_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"issue":"23","key":"10.1016\/j.cct.2008.03.006_bib18","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1002\/sim.1916","article-title":"Evaluation of log-rank tests for infrequent observations from a multi-state process, with application to HPV vaccine efficacy","volume":"23","author":"Kang","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.cct.2008.03.006_bib19","series-title":"The theory of stochastic processes","author":"Cox","year":"1987"},{"issue":"1","key":"10.1016\/j.cct.2008.03.006_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.cct.2008.03.006_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion","volume":"15","author":"Hagan","year":"2004","journal-title":"Epidemiology"},{"issue":"7","key":"10.1016\/j.cct.2008.03.006_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment","volume":"155","author":"Thorpe","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.cct.2008.03.006_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: a randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cct.2008.03.006_bib24","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/JCM.40.8.2903-2907.2002","article-title":"Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay","volume":"40","author":"Krajden","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"5 Suppl 1","key":"10.1016\/j.cct.2008.03.006_bib25","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/hep.1840360709","article-title":"Use and interpretation of virological tests for hepatitis C","volume":"36","author":"Pawlotsky","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cct.2008.03.006_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/sim.4780010204","article-title":"Tables of the number of patients required in clinical trials using the logrank test","volume":"1","author":"Freedman","year":"1982","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.cct.2008.03.006_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1191\/0962280204sm358ra","article-title":"Evaluating the role of human papillomavirus vaccine in cervical cancer prevention","volume":"13","author":"Kang","year":"2004","journal-title":"Stat Methods Med Res"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714408000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714408000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T06:00:14Z","timestamp":1546149614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714408000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1551714408000347"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2008.03.006","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}